JP2023547954A5 - - Google Patents

Info

Publication number
JP2023547954A5
JP2023547954A5 JP2023547721A JP2023547721A JP2023547954A5 JP 2023547954 A5 JP2023547954 A5 JP 2023547954A5 JP 2023547721 A JP2023547721 A JP 2023547721A JP 2023547721 A JP2023547721 A JP 2023547721A JP 2023547954 A5 JP2023547954 A5 JP 2023547954A5
Authority
JP
Japan
Prior art keywords
compound
formula
compound according
radioactive isotope
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023547721A
Other languages
English (en)
Japanese (ja)
Other versions
JP7890301B2 (ja
JP2023547954A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2021/051203 external-priority patent/WO2022077068A1/en
Publication of JP2023547954A publication Critical patent/JP2023547954A/ja
Publication of JP2023547954A5 publication Critical patent/JP2023547954A5/ja
Application granted granted Critical
Publication of JP7890301B2 publication Critical patent/JP7890301B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023547721A 2020-10-14 2021-10-14 治療用放射線標識コンジュゲート及び治療におけるそれらの使用 Active JP7890301B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2020903727 2020-10-14
AU2020903727A AU2020903727A0 (en) 2020-10-14 Conjugates and their use in therapy
PCT/AU2021/051203 WO2022077068A1 (en) 2020-10-14 2021-10-14 Therapeutic radiolabelled conjugates and their use in therapy

Publications (3)

Publication Number Publication Date
JP2023547954A JP2023547954A (ja) 2023-11-14
JP2023547954A5 true JP2023547954A5 (cg-RX-API-DMAC7.html) 2024-10-25
JP7890301B2 JP7890301B2 (ja) 2026-07-14

Family

ID=81207378

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023547721A Active JP7890301B2 (ja) 2020-10-14 2021-10-14 治療用放射線標識コンジュゲート及び治療におけるそれらの使用

Country Status (10)

Country Link
US (1) US20230398240A1 (cg-RX-API-DMAC7.html)
EP (1) EP4228710A4 (cg-RX-API-DMAC7.html)
JP (1) JP7890301B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230130610A (cg-RX-API-DMAC7.html)
CN (1) CN116472068A (cg-RX-API-DMAC7.html)
AU (1) AU2021359638A1 (cg-RX-API-DMAC7.html)
CA (1) CA3195410A1 (cg-RX-API-DMAC7.html)
IL (1) IL302033A (cg-RX-API-DMAC7.html)
MX (1) MX2023004327A (cg-RX-API-DMAC7.html)
WO (1) WO2022077068A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220152229A1 (en) 2019-04-12 2022-05-19 Centenary Institute Of Cancer Medicine And Cell Biology Conjugates and their use as imaging agents
US20250269072A1 (en) * 2021-10-14 2025-08-28 Centenary Institute Of Cancer Medicine And Cell Biology Processes for preparing radiolabelled conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100418585C (zh) * 2003-07-24 2008-09-17 伯拉考成像股份公司 稳定的放射性药物组合物及制备方法
WO2016088116A1 (en) * 2014-12-05 2016-06-09 University Health Network Use of antioxidants as radio-protective agents
LT3275883T (lt) 2015-03-25 2021-08-25 Fujifilm Corporation Naujo azotą turinčio junginio arba jo druskos gamybos būdas ir jo tarpinio junginio gamyba
US20160367620A1 (en) * 2015-06-19 2016-12-22 Harry B. Demopoulos Glutathione
US20220152229A1 (en) * 2019-04-12 2022-05-19 Centenary Institute Of Cancer Medicine And Cell Biology Conjugates and their use as imaging agents

Similar Documents

Publication Publication Date Title
ES2880103T3 (es) Derivados de benceno-1, 3, 5-tricarboxamida y usos de los mismos
CA2990696C (en) (r)- and (s)-1-(3-(3-n,n-dimethylaminocarbonyl)phenoxyl-4-nitrophenyl)-1-ethyl-n,n'-bis (ethylene)phosphoramidate, compositions and methods for their use and preparation
EP3041468B1 (en) Cyclic peptidomimetic compounds as immunomodulators
JP2023533938A5 (cg-RX-API-DMAC7.html)
CA3042731A1 (en) Inhibitors of interleukin-1 receptor-associated kinases and uses thereof
CA2637765A1 (en) Benzamide and heteroarene derivatives
JP2006502143A5 (cg-RX-API-DMAC7.html)
US11420949B2 (en) Cystine diamide analogs for the prevention of cystine stone formation in cystinuria
JPS6187691A (ja) 白金配位化合物
CA3157331A1 (en) A pyrazolopyrimidine derivative as a hck inhibitor for use in therapy, in particular myd88 mutated diseases
JP2023531970A5 (cg-RX-API-DMAC7.html)
US12043645B2 (en) Adenosine analogs as methyltransferase inhibitors for treating cancer
US10556875B2 (en) Bis-diazeniumdiolate compounds as anti-cancer agents
CN1942438A (zh) 在肿瘤治疗中用来作为药物活性成分的脯氨酸衍生物
JP2005501121A5 (cg-RX-API-DMAC7.html)
WO2024064210A1 (en) Small molecules for boron neutron capture therapy
RU2010120810A (ru) Гидратированные кристаллические сложные эфиры камптотецина для лечения рака
US12221459B2 (en) Cancer treatment with (2,2-bishydroxymethyl) methylenecyclopropane nucleotides
EP0317956A2 (en) Anti-tumor prodrugs
WO2020033377A1 (en) Histone demethylase 5 inhibitors and uses thereof
CN1882365A (zh) 金属三羰基络合物作为放射治疗化学毒性剂的用途
US8329879B2 (en) H3LMN compound used as radioactive agent for treatment of liver cancer and manufacturing method thereof
TW202227437A (zh) 作為蛋白激酶抑制劑的取代的吡咯並[2, 3-b]吡啶及吡唑並[3,4-b]吡啶衍生物
CN113766952B (zh) 放射性药品的制造方法及放射性药品
AU2009342892A1 (en) Radiolabeled fluorine derivatives of methionine